Nick Thomas-Symonds MP: speeches

Speeches

• 22 Apr 2026 · Pension Schemes · Hansard source

  More

  To be fair to the hon. Gentleman, he raises a reasonable point, and we are certainly monitoring Capita’s general position. Capita holds a total of 85 contracts across the public sector—39 with central Government and 46 with the wider public sector. He and the House can be assured that we monitor performance across the whole portfolio, and we obviously consider each contract individually. As he says, it is hugely important always to be looking at providers’ financial position, because continuity of service is so important for those who, in the case of the civil service pension scheme, have paid in their own money over decades and deserve dignity in retirement.

• 22 Apr 2026 · Pension Schemes · Hansard source

  More

  I, too, am grateful for the engagement with my hon. Friend, and we are certainly looking at how we learn the lessons of this matter. On her second point about the specific issue of compensation, a complaints procedure is available, as I think I have discussed with her previously, but there is also a very broad point here: I am determined that we will pursue every contractual lever to ensure that the taxpayer does not pick up the tab for the failure of MyCSP or Capita.

• 22 Apr 2026 · Pension Schemes · Hansard source

  More

  First of all, I echo the shadow Minister’s tribute to public servants, including his constituent Chris; I am very sorry to hear about his wife’s cancer diagnosis. I welcome what I think was his support for my decision to terminate the Royal Mail statutory pension scheme contract. On the civil service pension scheme, he asked about a plan; I have been implementing a plan, and I have come here to update the House on its implementation. He also talked about the contract. The Capita pension scheme contract was awarded by the previous Government in November 2023 on a long-term basis. That is what I inherited and have been trying to deal with. He talked about the point of transition; what I did at the point of transition was get in the Capita chief executive and the Cabinet Office permanent secretary to go through these matters, and to seek assurances. I am afraid to say that the assurances given have not been met. The shadow Minister talked about not meeting milestones; I can assure him that milestone payments have been withheld, and I will not hesitate to use the commercial levers in the contract to drive performance. I am absolutely clear about the restoration of service by the end of June; that is what I am holding Capita to. He also talked about MyCSP. I have said that we are reserving rights under both these contracts, with regard to the backlog that was left by MyCSP and how Capita has dealt with it since. In relation to MyCSP, there is also an option to pursue a parent company guarantee, and he can be assured that I will explore all possible legal options to ensure that the service that public servants rightly deserve—not just in retirement, but in very difficult circumstances, such as death in service—is being provided sensitively. The shadow Minister asked about forthcoming meetings and updates. I will consider the appropriate steps to take, and will update the House, and Members from across the House when they write to me.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I am grateful to the hon. Member for his generous comments. On that particular issue, I would be grateful if he wrote to me with the very specific details. I would be more than happy to see whether the claim is eligible. In an earlier question, the hon. Member for Keighley and Ilkley (Robbie Moore) asked about the potential for criminal prosecutions relating to this matter. Of course, prosecutions are a matter for the independent Crown Prosecution Service, but I have made it absolutely clear that the Government stand ready to provide any evidence required by the authorities.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  First, IBCA has published a prioritisation list. It published the rationale for that and is obviously moving through that list on the basis of that prioritisation. Given that this scandal happened over decades, there is obviously an urgency—it is shared by IBCA, me and the Government more widely—to get those payments to people as quickly as possible, including the hon. Gentleman’s constituent.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I thank the shadow Minister for the tone that he took in that response and for the supportive tone that he has taken throughout. I will pick up on some of his earlier points. I agree with him entirely when he talks of the heinous nature of the medical experimentation on children that happened during this scandal. Although I have increased the specific amounts, it should be pointed out that those amounts do not stand in isolation; they are specific amounts for the particularly egregious nature of what happened, which are within much higher settlements, and that is exactly as it should be. On the point about the inquiry, yes, there has now been the formal exchange of letters between me as the responsible Minister and Sir Brian Langstaff. Also, I entirely agree with the shadow Minister about the need for policy certainty going forward. He asked some very reasonable, detailed questions, and I will come back to him properly in writing on those, but let me just deal with a few of them. I want to bring forward further legislation as soon as possible. When I have brought forward legislation in the past, parties across the House have always worked in a collaborative way throughout to get it through as quickly as possible. Obviously, positions are a matter for the Opposition parties, but continuing that constructive spirit is helpful in getting these things through as quickly as possible. On the issue of exceptional loss, again, that £60,000, as referred to by the shadow Minister, is not designed to be a very detailed, individualised assessment. That is not what a tariff-based scheme is meant to do. Rather, it is meant to look at the situation of loss of a chance—the situation where somebody, but for their infection or how they were affected by the infection, would have had the opportunity to have gone on and perhaps been a higher-than-average earner but were denied that—and is designed specifically to look at that. On the other very reasonable and detailed matters that the hon. Gentleman raises, I will ensure he gets a full written response.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  One of the reasons I signed off funding for both financial advice and legal advice was precisely to ensure that, in a situation where an offer of compensation was received, people could access it. Obviously, I do not know whether that opportunity was taken in that particular case, but if the hon. Gentleman would write to me with the circumstances, I can certainly look into it.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  On the right hon. Gentleman’s third question, the answer is yes. His second question related to dates. There are some specific dates that exist in the scheme. For example, assessment for the special category mechanism started in 2017, so that is the date that exists in relevant cases. Finally, I want to bring forward the regulations—this will be the fourth set of regulations—as soon as I possibly can. When I do so, I very much hope that we can collectively deal with them as quickly as possible.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend’s constituent is entirely right to continue to hold the Government to account on the speed of delivery of the compensation. Particular targets were put in place, including paying the first affected person by the end of last year, and we met that target. On infected people, we have now paid out over £2 billion in compensation. To answer his specific point on how we will continue to ensure that we process the payments at speed, while IBCA is of course operationally independent, I always stand ready as the responsible Minister to assist IBCA in any way that it sees fit. I can assure my hon. Friend that my dialogue with IBCA on this point will continue.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I am grateful to the hon. Gentleman and his party for the tone that they have taken throughout this process, and I welcome the opportunity to continue to work on a cross-party basis, because that is important. Like him, I have had that discussion with the charities—including the Hepatitis C Trust, as it happens—and I very much understand the case they make about multi-year funding as opposed to single-year funding. The funding comes from the Department of Health and Social Care, rather than from me, but I will certainly write to the relevant Minister to raise that point. The introduction of level 2B banding for interferon treatment is important, because of the specific, awful effects of multiple rounds of interferon treatment. On the two points that the hon. Gentleman has specifically raised, I will ensure that he gets a detailed answer in writing.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I am grateful to the right hon. Gentleman for his generous tribute. I have built on the work that he did as a Minister, and I think that the consensus between us, when I was in opposition and now as I am in government, has helped the victims and speeded up the process. I am very grateful for all the work that he did. His second point was very well made. We have to look at the public inquiries landscape. We all recognise that public inquiries provide a real public sense of justice when people have suffered either from a scandal or, frankly, from a cover-up by the state, but we want public inquiries to provide value for money for the taxpayer and to report in a timely fashion. We also need them to make relevant, timely policy recommendations. I am determined to look at that.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I am grateful to the hon. Gentleman for his remarks and for his support and that of his party, which has been helpful throughout this process. On existing claims where there has been a change, the objective is to make the process as easy as possible, because I do not want to go back to the situation where people are being asked repeatedly to produce different pieces of evidence. Where there is an impact on an existing claim, the intention is absolutely to make it as easy as it can be.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  First, in respect of the feedback mechanism, I wanted it to be not simply somewhere that would receive correspondence, but a proper mechanism to sift the various queries coming in. Some might be administrative things to do with the scheme that might be dealt with relatively quickly and some might be more serious things that need to be elevated either to IBCA’s board or to the Cabinet Office. Secondly, with regard to IBCA and the voice of victims, I have been on more than one occasion to IBCA’s offices in Newcastle. It already has what are known as the user consultants, who provide the voice of the community on the premises and who have been encouraged by Sir Robert Francis to do that. I think they make a very important contribution. Thirdly, on transparency, I could not agree more. That is why, on the technical expert group for example, I take the view of publishing everything. I think we have to continue to do that. Fourthly, on the issue of the Hillsborough law, work is ongoing. I have been very involved in that in recent months and, certainly, we are committed to delivering it.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I should say that 2029 is a backstop not a target, so it is not a question of my being confident about that date; I want the payments to have been made before 2029. On the hon. Member’s more general point about speeding up payments, IBCA has used a “test and learn” approach for infected people. The reason for that was to have a small number of representative cases, so that there could be an accelerating point at which the number of cases being paid would increase sharply. That did happen and I would say, as the Minister, that we are now up to over £2 billion having been paid, but he is absolutely right to continue to hold me to account on the speed of payments.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend highlights a really important point. This is why the feedback mechanism is so important in ensuring that, where there are issues, they are treated sensitively and with the seriousness they deserve, and that they are elevated to the appropriate place, whether that is IBCA’s board or the Cabinet Office, to be dealt with.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I thank my hon. Friend and pay tribute to his work with the all-party parliamentary group on haemophilia and contaminated blood, which I was pleased to attend and speak to in recent weeks. He is absolutely right about the new feedback mechanism. It is so important not only that victims feel that their voice can be heard, but that they have a specific process whereby they can raise those concerns and then be elevated to the appropriate person to respond to them. That will be hugely important going forward.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  I join the hon. Gentleman in paying tribute to Clive Smith for his excellent and continuing work on memorialisation in particular, for which I am very grateful. The hon. Gentleman rightly raises the heinous activities that happened at Treloar’s school, which was a place that parents sent their children—vulnerable children—for protection, and then had this truly chilling medical experimentation that happened. We will ensure that things move as quickly as possible, but I also say to the hon. Gentleman that we must ensure that we learn the lessons of what happened there to ensure that something like that never happens again.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  First, the intention is certainly not to produce any form of two-tier scheme; it is to compensate everybody for the harm they have suffered. On the hon. Gentleman’s constituent, I would greatly appreciate it if he would write to me with the particular individual circumstances and then I can look specifically at what has happened in that case.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend is absolutely right to speak of those people who were infected with HIV in the period that she talks about and the terrible social stigma, alongside everything else that they suffered. Indeed, I sincerely hope that the scheme reflects that. On the second, very specific question that she raises, if she could send me the details of her constituents, I will come back to her on that particular case.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend raises a really important point. An issue with this scandal is that, due to the passage of time, evidence will simply not be available. Also, the inquiry found evidence of deliberate document destruction. That is why, while of course I entirely respect IBCA’s independence, I have always said that a sympathetic approach needs to be taken to evidence in that particular context. Indeed, from conversations I have had with Sir Robert Francis and others at IBCA, I know that that is precisely the approach they are seeking to take.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  Whether it is in relation to the co-infected, to whom my hon. Friend so movingly refers, or other people who are both infected and affected by this scandal, the compensation scheme seeks to recognise everything—all the harms that have happened to them and how they have suffered. I will just say, though, that this was always meant to be a tariff-based scheme—it is meant to produce broad justice—and part of the reason for that is to try to prevent those highly individualised searches for evidence which, frankly, with this distance of time, would simply not be possible.

• 14 Apr 2026 · Infected Blood Compensation Scheme · Hansard source

  More

  With permission, I will update the House on the Government’s response to the recommendations of the infected blood inquiry’s additional report. I will start by updating the House on the delivery of compensation by the Infected Blood Compensation Authority—or IBCA, as we refer to it. As of 7 April, 3,273 people have received an offer and over £2 billion has now been paid out. That includes the first payments to all eligible groups. I am sure that Members across the whole House will welcome that progress. In July last year, the infected blood inquiry published its additional report, which made recommendations for both the Government and IBCA. Part of our response to that report was a public consultation on changes to the infected blood compensation scheme. I am here today to update the House on the outcome of that consultation. First, I should say that I am deeply grateful to everyone who responded and provided deeply personal stories. They must be at the heart of the decisions that the Government make, just as they were throughout the work of the inquiry. The consultation was vital for engaging the community on our proposals. The Government have also sought advice from the infected blood compensation scheme technical expert group. Alongside the consultation response, today I am publishing the group’s final report, which sets out its advice to the Government and amendments to the compensation scheme. To inform that advice, the technical expert group conducted roundtable discussions with community representatives on specific aspects of the scheme, and that was separate to the consultation. For transparency, I am also publishing the minutes of the roundtable discussions, the group’s own meetings and a summary of written responses to the roundtables. Let me turn to the changes to the scheme. Today the Government have published our full response to the consultation, and that sets out how the scheme will now change. Before I lay out each change in detail, let me explain the overall package. The community was clear that the scheme must do more to recognise people’s individual experiences and compensate them fairly in a way that minimises the administrative burden placed on those who have been harmed, minimises the demand for evidence and maintains the delivery of tariff-based compensation. Those requirements underpin the changes. For infected people, the changes will increase the amount of core compensation available and increase the options available for supplementary compensation awards. For affected people, additional core compensation will be available to those eligible. We consulted on seven specific areas, and we are making substantive changes in all seven. In four areas, we are actually going further than our original proposal. Let me turn first to the special category mechanism. We will introduce a new supplementary award to give additional compensation to people who have been assessed as eligible for the SCM or who can now demonstrate to IBCA that they meet the criteria. After considering the community’s views, we will ensure that every eligible person has this award backdated to 2017, because that is when the special category mechanism was first introduced. Many of those infected suffered from terrible mental health issues as a result of their infection, as we heard in their testimonies. We will amend the scheme so that the new SCM supplementary award gives people additional compensation where the psychological harm that they experienced means that the core route compensation simply does not go far enough. We believe that this will result in more comprehensive recognition of the mental health issues caused by infected blood and the resulting years of harm. The inquiry recommended that we change the core route’s severity bandings to recognise the harms caused to infected people by interferon treatment, and proposed a new “level 2B” severity banding for those who receive this treatment. We accept that change is necessary, and we will introduce this new severity band to increase people’s injury, financial loss and care awards. In addition, if someone has had multiple rounds of interferon treatment, they will be compensated for each round. The inquiry recommended changes to the calculation of past financial loss and past care awards for those who choose to continue receiving support scheme payments. We will remove the 25% deduction applied to past care compensation, as was recommended by the inquiry. The consultation also set out two options for how financial loss could be calculated for those who continue to receive support scheme payments: the way the scheme currently does it, and an alternative. Because of the range of views on which was best, we will ensure that people receive past financial loss compensation based on whichever of the two calculations presented is most financially beneficial for them. The inquiry asked the Government to look at the evidence requirements for the exceptional loss award. We were keen to hear the community’s views on that in order to develop a way forward that avoided lengthy, individualised assessments of people’s circumstances. We will ensure that all forms of evidence of actual earnings can be considered by IBCA. We will also make additional compensation available to infected people who lack evidence of earnings but who had clear potential to earn more than average. We will offer a £60,000 lump sum on top of people’s core awards to those who can show they either had a job offer or recently started a job where the salary was higher than the median salary but had their progress impeded by their infection. Through the consultation, we also heard about the experiences of affected people and the particular harms they suffered. We will increase the core injury award for several groups of affected people, including bereaved parents whose child sadly died before they turned 18, bereaved partners, and children and siblings affected under the age of 18. Those changes will give more compensation to affected people whose particular experience of the scandal was undoubtedly profound and deeply harmful. The awards will form part of the core award, and they will not require additional evidence from applicants. I know that the matter of unethical research is of particular concern to Members across the House. It is one of the most shocking aspects of the scandal. We heard that the existing approach may not have compensated everyone who suffered that wrongdoing. We have therefore changed the scope of the award so that anyone treated in the UK for a bleeding disorder in 1985 or earlier will receive further compensation. It was also clear from the consultation responses that the amount offered does not reflect the harm done. I say today to the House that we will increase the unethical research awards. That includes increasing the £25,000 for those who attended Treloar’s school to £60,000 as well as introducing a new unethical research award for those treated elsewhere for a bleeding disorder during childhood at a rate of £45,000. We are also tripling the award for those treated for a bleeding disorder in adulthood to £30,000. I have touched on all seven of the areas we directly addressed in the consultation; of course, I encourage hon. Members across the House to read the full response that is being published. The consultation also invited respondents to raise any other concerns they had about the design of the scheme. One of the most compelling things we heard was that the scheme does not sufficiently recognise the profound impact of infection during childhood. We have heard the community clearly on that, so we will make a further change to the compensation scheme to address it: we will introduce a 50% increase to the core autonomy award for people who were infected at age 18 or under. Official Report , 25 June 2026; Vol. 788, c. 2WC. (Correction). I hope those changes go some way to showing our commitment to listening to the community and making decisions, with those impacted at the forefront of our minds. In order to make those substantial changes to the scheme, we will bring forward further legislation in due course. While the consultation provided one way for the community to offer feedback, the inquiry recommended there be an identified way for concerns to be considered. Today, I am pleased to launch a new mechanism that builds on existing engagement and feedback channels through which people can raise concerns about the function of the infected blood compensation scheme with the Cabinet Office and with IBCA. Both organisations will then publish quarterly summaries of feedback received on the scheme’s design and delivery, and any action being taken as a result. I expect the first of those summaries to be published in early July. The findings of the inquiry must be met with tangible, systemic change. I hope that what I have set out goes some way towards showing our commitment to enacting this change. I pay tribute to Sir Brian Langstaff, his team and everyone who gave testimony to the inquiry for ensuring that that human element of this tragedy remains a focal point of the inquiry’s work. The compensation scheme’s most basic purpose is to provide financial recognition of the losses and harms faced by victims, both infected and affected. Beyond that, it must reflect and embody their stories if it is to truly deliver justice, not just for those we tragically lost, but for those who continue to fight. I commend this statement to the House.

• 17 Mar 2026 · Ministerial Salaries (Amendment) Bill · Hansard source

  More

  I beg to move, That the Bill be now read the Third time. I will keep my remarks brief. I just want to thank Members across the House for their contributions to the debate. I am sure there are issues of House of Lords reform that are far wider than this Bill, and that we will continue the debate on that in due course. If I may say a word to the officials and the team who put the Bill together, Members across the House are grateful for their work. I commend this Bill to the House. Question put and agreed to. Bill accordingly read the Third time and passed.

• 17 Mar 2026 · Ministerial Salaries (Amendment) Bill · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Mrs Cummins, as I open the proceedings in the Committee of the whole House. I set out the core arguments for this Bill in my Second Reading speech, so I will not rehearse them again, although I have not matched the Teddy Taylor standard from 1975. However, for the benefit of the Committee, I will outline the two clauses and why they should stand part of the Bill. Clause 1 amends paragraph 2 of part V of schedule 1 to the Ministerial and other Salaries Act 1975, which determines the maximum number of salaries that may be paid to certain ministerial office holders. Sub-paragraph (a) replaces the previous provision for 21 salaries at Secretary of State rank with a new provision for 22 salaries, sub-paragraph (b) replaces the previous provision for 50 salaries at Secretary of State rank and Minister of State rank with a new provision for 54 salaries, and sub-paragraph (c) replaces the previous provision for 83 salaries at Secretary of State rank, Minister of State rank and Parliamentary Secretary rank with a new provision of 94 salaries. This increases the total number of ministerial salaries available by 11. As I have said, the new limits are cumulative, meaning that the Prime Minister has the discretion to allocate salaries to a large number of Ministers at more junior ranks within those limits, if so desired. Clause 2 sets out the extent, commencement and short title of the Bill. The Bill extends to England and Wales, Scotland and Northern Ireland. Of course, the Bill comes into force on Royal Assent. I very much look forward to the rest of the debate and seeing the Bill on the statute book soon.

• 17 Mar 2026 · Ministerial Salaries (Amendment) Bill · Hansard source

  More

  I will try to be brief on those two questions. It was the usual precise contribution, as ever, from the shadow Chancellor of the Duchy of Lancaster. First, why those totals? Because they reflect the average practice since 2010. Perhaps to reassure the hon. Gentleman, we are trying to look at the existing practice rather than looking at additional totals in the future. Secondly, on whether we are ending the practice of having unpaid Ministers, which has largely been ended, that is exactly the intention of the Bill. Question put and agreed to. Clause 1 accordingly ordered to stand part of the Bill. Clause 2 ordered to stand part of the Bill. The Deputy Speaker resumed the Chair. Bill reported, without amendment. Third Reading